Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1990-02

AUTHORS

Neil G. Anderson, James L. Maller, Nicholas K. Tonks, Thomas W. Sturgill

ABSTRACT

MAP kinase (relative molecular mass, 42,000), a low abundance serine-threonine protein kinase, is transiently activated in many cell types by a variety of mitogens, including insulin, epidermal growth factor, and phorbol esters1,2. In vitro, MAP kinase will phosphorylate and reactivate S6 kinase II previously inactivated by phosphatase treatment3. Because many of the stimuli that activate MAP kinase are also stimulators of cell proliferation, and regulation of the cell cycle seems to involve a network of protein kinases, MAP kinase could be important in the transmission of stimuli eventually leading to the progression from GO to Gl in the cell cycle. Activated MAP kinase contains both phosphotyrosine and phosphothreonine4. We report here that MAP kinase can be deactivated completely by treatment with either phosphatase 2A, a protein phosphatase specific for phosphoserine and phosphothreonine, or CD45, a phosphotyrosine-specific protein phosphatase. We demonstrate that MAP kinase is only active when both tyrosyl and threonyl residues are phosphorylated and suggest therefore that the enzyme functions in vivo to integrate signals from two distinct transduction pathways. More... »

PAGES

651-653

Journal

TITLE

Nature

ISSUE

6259

VOLUME

343

Related Patents

  • Oncoprotein Protein Kinase
  • Human Signal Transduction Mapk Kinase
  • Aminopyrimidines Useful As Kinase Inhibitors
  • Substituted Pyrimidines Useful As Protein Kinase Inhibitors
  • Aminopyrimidines Useful As Kinase Inhibitors
  • Inhibition Of Signal Transduction Molecules
  • Processes For Preparing Substituted Pyrimidines
  • Oncoprotein Protein Kinase
  • Oncoprotein Protein Kinase
  • Detection Of Modulators Or Kinase Activity; Obtain Sample Containing Kinase, Incubate With Modulators, Monitor Adjustment In Enzyme Activity, Adjustment In Activity Indicates Modulator
  • Mapk/Erk Kinase Inhibitors
  • Thiazoles And Pyrazoles Useful As Kinase Inhibitors
  • Method For Assaying Erk2 Map Kinase
  • Serine And Threonine Kinase Activity
  • Oncoprotein Kinase
  • Co-Crystals And Pharmaceutical Formulations Comprising The Same
  • Pyrazole Compositions Useful As Inhibitors Of Erk
  • Aminopyrimidines Useful As Kinase Inhibitors
  • Oncoprotein Protein Kinase
  • Using Lymphocytes Expressing Jun Kinase As Tools In Detecting Modulators For Treatment Of Cell Proliferative Disorders
  • Oncoprotein Protein Kinase
  • Inhibitors Of Flt-3, Aurora-1, Aurora-2, And Aurora-3 Protein Kinases; Leukemia; N-{4-[4-(5-Methyl-2h-Pyrazol-3-Ylmethyl)-6-(4-Propyl-Piperazin-1-Yl)-Pyrim- Idin-2-Ylsulfanyl]-Phenyl}-Propionamide
  • Inhibitors Of Aurora Protein Kinases; Antiproliferative Agents; Melanoma, Myeloma, Leukemia, Lymphoma, Neuroblastoma, And Cancer; N-(4-(4-(3-Methyl-1h-Pyrazol-5-Ylamino)-6-Chloropyrimidin-2-Ylthio)Phenyl)Cyclopentanecarboxamide
  • Inhibitors Of Aurora Protein Kinases; Antiproliferative Agents; Melanoma, Myeloma, Leukemia, Lymphoma, Neuroblastoma, And Cancer; N-(4-(4-(3-Methyl-1h-Pyrazol-5-Ylamino)-6-Chloropyrimidin-2-Ylthio)Phenyl)Cyclopentanecarboxamide
  • Oncoprotein Protein Kinase
  • Pyrazole Compounds Useful As Protein Kinase Inhibitors
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/343651a0

    DOI

    http://dx.doi.org/10.1038/343651a0

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1015375932

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/2154696


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biological Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biochemistry and Cell Biology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adenosine Triphosphate", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Amino Acids", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antigens, Differentiation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Calcium-Calmodulin-Dependent Protein Kinases", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cells, Cultured", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Enzyme Activation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Histocompatibility Antigens", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Kinetics", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Leukocyte Common Antigens", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Membrane Glycoproteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Molecular Weight", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Phosphoprotein Phosphatases", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Phosphorus Radioisotopes", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Phosphorylation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Protein Kinases", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Protein Phosphatase 2", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Sodium Fluoride", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Substrate Specificity", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Internal Medicine and Pharmacology, University of Virginia School of Medicine, 22908, Charlottesville, Virginia, USA", 
              "id": "http://www.grid.ac/institutes/grid.27755.32", 
              "name": [
                "Department of Internal Medicine and Pharmacology, University of Virginia School of Medicine, 22908, Charlottesville, Virginia, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Anderson", 
            "givenName": "Neil G.", 
            "id": "sg:person.0747602406.42", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0747602406.42"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pharmacology, University of Colorado School of Medicine, 80262, Denver, Colorado, USA", 
              "id": "http://www.grid.ac/institutes/grid.241116.1", 
              "name": [
                "Department of Pharmacology, University of Colorado School of Medicine, 80262, Denver, Colorado, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Maller", 
            "givenName": "James L.", 
            "id": "sg:person.0634071120.21", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634071120.21"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Biochemistry, University of Washington, 98195, Seattle, Washington, USA", 
              "id": "http://www.grid.ac/institutes/grid.34477.33", 
              "name": [
                "Department of Biochemistry, University of Washington, 98195, Seattle, Washington, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tonks", 
            "givenName": "Nicholas K.", 
            "id": "sg:person.0713330356.77", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713330356.77"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Internal Medicine and Pharmacology, University of Virginia School of Medicine, 22908, Charlottesville, Virginia, USA", 
              "id": "http://www.grid.ac/institutes/grid.27755.32", 
              "name": [
                "Department of Internal Medicine and Pharmacology, University of Virginia School of Medicine, 22908, Charlottesville, Virginia, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sturgill", 
            "givenName": "Thomas W.", 
            "id": "sg:person.0107140407.03", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0107140407.03"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/334715a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028437472", 
              "https://doi.org/10.1038/334715a0"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1990-02", 
        "datePublishedReg": "1990-02-01", 
        "description": "MAP kinase (relative molecular mass, 42,000), a low abundance serine-threonine protein kinase, is transiently activated in many cell types by a variety of mitogens, including insulin, epidermal growth factor, and phorbol esters1,2. In vitro, MAP kinase will phosphorylate and reactivate S6 kinase II previously inactivated by phosphatase treatment3. Because many of the stimuli that activate MAP kinase are also stimulators of cell proliferation, and regulation of the cell cycle seems to involve a network of protein kinases, MAP kinase could be important in the transmission of stimuli eventually leading to the progression from GO to Gl in the cell cycle. Activated MAP kinase contains both phosphotyrosine and phosphothreonine4. We report here that MAP kinase can be deactivated completely by treatment with either phosphatase 2A, a protein phosphatase specific for phosphoserine and phosphothreonine, or CD45, a phosphotyrosine-specific protein phosphatase. We demonstrate that MAP kinase is only active when both tyrosyl and threonyl residues are phosphorylated and suggest therefore that the enzyme functions in vivo to integrate signals from two distinct transduction pathways.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/343651a0", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1018957", 
            "issn": [
              "0028-0836", 
              "1476-4687"
            ], 
            "name": "Nature", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "6259", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "343"
          }
        ], 
        "keywords": [
          "MAP kinase", 
          "protein phosphatase", 
          "protein kinase", 
          "phosphotyrosine-specific protein phosphatase", 
          "serine-threonine protein kinase", 
          "cell cycle", 
          "S6 kinase II", 
          "activated MAP kinase", 
          "integration of signals", 
          "phosphatase 2A", 
          "distinct transduction pathways", 
          "transduction pathways", 
          "epidermal growth factor", 
          "phosphorylation pathway", 
          "kinase II", 
          "threonyl residues", 
          "enzyme function", 
          "kinase", 
          "cell types", 
          "transmission of stimuli", 
          "variety of mitogens", 
          "cell proliferation", 
          "growth factor", 
          "phosphatase", 
          "pathway", 
          "phosphotyrosine", 
          "phosphothreonine", 
          "phosphoserine", 
          "residues", 
          "mitogen", 
          "regulation", 
          "tyrosyl", 
          "phorbol", 
          "proliferation", 
          "activation", 
          "vivo", 
          "cycle", 
          "CD45", 
          "signals", 
          "progression", 
          "stimuli", 
          "treatment3", 
          "function", 
          "insulin", 
          "variety", 
          "stimulator", 
          "GL", 
          "GO", 
          "factors", 
          "types", 
          "transmission", 
          "treatment", 
          "network", 
          "integration", 
          "requirements"
        ], 
        "name": "Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase", 
        "pagination": "651-653", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1015375932"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/343651a0"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "2154696"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/343651a0", 
          "https://app.dimensions.ai/details/publication/pub.1015375932"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-10-01T06:29", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_243.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/343651a0"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/343651a0'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/343651a0'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/343651a0'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/343651a0'


     

    This table displays all metadata directly associated to this object as RDF triples.

    227 TRIPLES      21 PREDICATES      102 URIs      93 LITERALS      27 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/343651a0 schema:about N01bb82f0aff64591baf155da3a144bd2
    2 N063753a852564c0cad732be835113868
    3 N06455f1f25fb47f1a9fe4e6f53bcdcdc
    4 N14fc02f79c0f4f2c909924b6043c24a0
    5 N31c49c6b36dc423d9369d7cdd7c978e8
    6 N487535d2f09c452db82532ee89b923ea
    7 N4983ce99c9eb4fc0abb2844a6d41cbfc
    8 N65257ffc2a52485f906e820c4854d25e
    9 N70a7a7a31ceb41b5b7b0c082cff5f6e2
    10 N9777cc3b784f4d4d9dc03b47d50feb94
    11 N9d2d521a15c34f95999277eb6ddbfb41
    12 Na095f04fa0b74eb896ad283654414960
    13 Na6bad2909c484b4385c58bd34c1f3dda
    14 Na7e12db1e54549099a8481ea1e6ed896
    15 Nb4623699e75b476dbdba5362b1a227a6
    16 Nbc08e832a2664a31b8bf2ba0a64d7f6f
    17 Nc16e251da80444a0bd51585252282212
    18 Ncf498addcbfc468b9182c0cf7f169ec0
    19 Nd84497ccb90c4d4eb5b99b6a772507da
    20 Nf588c9f8ee404e0083990f706e5971c0
    21 anzsrc-for:06
    22 anzsrc-for:0601
    23 schema:author N21dbefd6a5704388bfc11d0a3a951e10
    24 schema:citation sg:pub.10.1038/334715a0
    25 schema:datePublished 1990-02
    26 schema:datePublishedReg 1990-02-01
    27 schema:description MAP kinase (relative molecular mass, 42,000), a low abundance serine-threonine protein kinase, is transiently activated in many cell types by a variety of mitogens, including insulin, epidermal growth factor, and phorbol esters1,2. In vitro, MAP kinase will phosphorylate and reactivate S6 kinase II previously inactivated by phosphatase treatment3. Because many of the stimuli that activate MAP kinase are also stimulators of cell proliferation, and regulation of the cell cycle seems to involve a network of protein kinases, MAP kinase could be important in the transmission of stimuli eventually leading to the progression from GO to Gl in the cell cycle. Activated MAP kinase contains both phosphotyrosine and phosphothreonine4. We report here that MAP kinase can be deactivated completely by treatment with either phosphatase 2A, a protein phosphatase specific for phosphoserine and phosphothreonine, or CD45, a phosphotyrosine-specific protein phosphatase. We demonstrate that MAP kinase is only active when both tyrosyl and threonyl residues are phosphorylated and suggest therefore that the enzyme functions in vivo to integrate signals from two distinct transduction pathways.
    28 schema:genre article
    29 schema:isAccessibleForFree false
    30 schema:isPartOf N5466fb32dcf64ff4ba10c233ef9d5531
    31 N64731350d716478bb359c21696ebd9c7
    32 sg:journal.1018957
    33 schema:keywords CD45
    34 GL
    35 GO
    36 MAP kinase
    37 S6 kinase II
    38 activated MAP kinase
    39 activation
    40 cell cycle
    41 cell proliferation
    42 cell types
    43 cycle
    44 distinct transduction pathways
    45 enzyme function
    46 epidermal growth factor
    47 factors
    48 function
    49 growth factor
    50 insulin
    51 integration
    52 integration of signals
    53 kinase
    54 kinase II
    55 mitogen
    56 network
    57 pathway
    58 phorbol
    59 phosphatase
    60 phosphatase 2A
    61 phosphorylation pathway
    62 phosphoserine
    63 phosphothreonine
    64 phosphotyrosine
    65 phosphotyrosine-specific protein phosphatase
    66 progression
    67 proliferation
    68 protein kinase
    69 protein phosphatase
    70 regulation
    71 requirements
    72 residues
    73 serine-threonine protein kinase
    74 signals
    75 stimulator
    76 stimuli
    77 threonyl residues
    78 transduction pathways
    79 transmission
    80 transmission of stimuli
    81 treatment
    82 treatment3
    83 types
    84 tyrosyl
    85 variety
    86 variety of mitogens
    87 vivo
    88 schema:name Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase
    89 schema:pagination 651-653
    90 schema:productId N84e62c773bb54429b8a83bf492a51947
    91 Ne0f8c69bd28045febcbb434f5568eff8
    92 Ne5c6970a225e4cf3899f5b1dcd5dca49
    93 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015375932
    94 https://doi.org/10.1038/343651a0
    95 schema:sdDatePublished 2022-10-01T06:29
    96 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    97 schema:sdPublisher Na239502f10b542fdad9670332ee1bb43
    98 schema:url https://doi.org/10.1038/343651a0
    99 sgo:license sg:explorer/license/
    100 sgo:sdDataset articles
    101 rdf:type schema:ScholarlyArticle
    102 N01bb82f0aff64591baf155da3a144bd2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    103 schema:name Animals
    104 rdf:type schema:DefinedTerm
    105 N063753a852564c0cad732be835113868 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    106 schema:name Adenosine Triphosphate
    107 rdf:type schema:DefinedTerm
    108 N06455f1f25fb47f1a9fe4e6f53bcdcdc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    109 schema:name Kinetics
    110 rdf:type schema:DefinedTerm
    111 N14fc02f79c0f4f2c909924b6043c24a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    112 schema:name Calcium-Calmodulin-Dependent Protein Kinases
    113 rdf:type schema:DefinedTerm
    114 N21dbefd6a5704388bfc11d0a3a951e10 rdf:first sg:person.0747602406.42
    115 rdf:rest N2b364e0c20f9454aa91e4ae80871dff3
    116 N2b364e0c20f9454aa91e4ae80871dff3 rdf:first sg:person.0634071120.21
    117 rdf:rest N8e9458e3c2c144beb5e739c6f5d08349
    118 N31c49c6b36dc423d9369d7cdd7c978e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    119 schema:name Histocompatibility Antigens
    120 rdf:type schema:DefinedTerm
    121 N487535d2f09c452db82532ee89b923ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    122 schema:name Enzyme Activation
    123 rdf:type schema:DefinedTerm
    124 N4983ce99c9eb4fc0abb2844a6d41cbfc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    125 schema:name Leukocyte Common Antigens
    126 rdf:type schema:DefinedTerm
    127 N5466fb32dcf64ff4ba10c233ef9d5531 schema:volumeNumber 343
    128 rdf:type schema:PublicationVolume
    129 N64731350d716478bb359c21696ebd9c7 schema:issueNumber 6259
    130 rdf:type schema:PublicationIssue
    131 N65257ffc2a52485f906e820c4854d25e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    132 schema:name Phosphorylation
    133 rdf:type schema:DefinedTerm
    134 N70a7a7a31ceb41b5b7b0c082cff5f6e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    135 schema:name Amino Acids
    136 rdf:type schema:DefinedTerm
    137 N84e62c773bb54429b8a83bf492a51947 schema:name pubmed_id
    138 schema:value 2154696
    139 rdf:type schema:PropertyValue
    140 N8e9458e3c2c144beb5e739c6f5d08349 rdf:first sg:person.0713330356.77
    141 rdf:rest N920422ed398e4c85ad4d48d4b6e82f4d
    142 N920422ed398e4c85ad4d48d4b6e82f4d rdf:first sg:person.0107140407.03
    143 rdf:rest rdf:nil
    144 N9777cc3b784f4d4d9dc03b47d50feb94 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    145 schema:name Phosphoprotein Phosphatases
    146 rdf:type schema:DefinedTerm
    147 N9d2d521a15c34f95999277eb6ddbfb41 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    148 schema:name Membrane Glycoproteins
    149 rdf:type schema:DefinedTerm
    150 Na095f04fa0b74eb896ad283654414960 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    151 schema:name Molecular Weight
    152 rdf:type schema:DefinedTerm
    153 Na239502f10b542fdad9670332ee1bb43 schema:name Springer Nature - SN SciGraph project
    154 rdf:type schema:Organization
    155 Na6bad2909c484b4385c58bd34c1f3dda schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    156 schema:name Cells, Cultured
    157 rdf:type schema:DefinedTerm
    158 Na7e12db1e54549099a8481ea1e6ed896 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    159 schema:name Antigens, Differentiation
    160 rdf:type schema:DefinedTerm
    161 Nb4623699e75b476dbdba5362b1a227a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    162 schema:name Protein Phosphatase 2
    163 rdf:type schema:DefinedTerm
    164 Nbc08e832a2664a31b8bf2ba0a64d7f6f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    165 schema:name Mice
    166 rdf:type schema:DefinedTerm
    167 Nc16e251da80444a0bd51585252282212 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    168 schema:name Sodium Fluoride
    169 rdf:type schema:DefinedTerm
    170 Ncf498addcbfc468b9182c0cf7f169ec0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    171 schema:name Substrate Specificity
    172 rdf:type schema:DefinedTerm
    173 Nd84497ccb90c4d4eb5b99b6a772507da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    174 schema:name Protein Kinases
    175 rdf:type schema:DefinedTerm
    176 Ne0f8c69bd28045febcbb434f5568eff8 schema:name doi
    177 schema:value 10.1038/343651a0
    178 rdf:type schema:PropertyValue
    179 Ne5c6970a225e4cf3899f5b1dcd5dca49 schema:name dimensions_id
    180 schema:value pub.1015375932
    181 rdf:type schema:PropertyValue
    182 Nf588c9f8ee404e0083990f706e5971c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    183 schema:name Phosphorus Radioisotopes
    184 rdf:type schema:DefinedTerm
    185 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
    186 schema:name Biological Sciences
    187 rdf:type schema:DefinedTerm
    188 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
    189 schema:name Biochemistry and Cell Biology
    190 rdf:type schema:DefinedTerm
    191 sg:journal.1018957 schema:issn 0028-0836
    192 1476-4687
    193 schema:name Nature
    194 schema:publisher Springer Nature
    195 rdf:type schema:Periodical
    196 sg:person.0107140407.03 schema:affiliation grid-institutes:grid.27755.32
    197 schema:familyName Sturgill
    198 schema:givenName Thomas W.
    199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0107140407.03
    200 rdf:type schema:Person
    201 sg:person.0634071120.21 schema:affiliation grid-institutes:grid.241116.1
    202 schema:familyName Maller
    203 schema:givenName James L.
    204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634071120.21
    205 rdf:type schema:Person
    206 sg:person.0713330356.77 schema:affiliation grid-institutes:grid.34477.33
    207 schema:familyName Tonks
    208 schema:givenName Nicholas K.
    209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713330356.77
    210 rdf:type schema:Person
    211 sg:person.0747602406.42 schema:affiliation grid-institutes:grid.27755.32
    212 schema:familyName Anderson
    213 schema:givenName Neil G.
    214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0747602406.42
    215 rdf:type schema:Person
    216 sg:pub.10.1038/334715a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028437472
    217 https://doi.org/10.1038/334715a0
    218 rdf:type schema:CreativeWork
    219 grid-institutes:grid.241116.1 schema:alternateName Department of Pharmacology, University of Colorado School of Medicine, 80262, Denver, Colorado, USA
    220 schema:name Department of Pharmacology, University of Colorado School of Medicine, 80262, Denver, Colorado, USA
    221 rdf:type schema:Organization
    222 grid-institutes:grid.27755.32 schema:alternateName Department of Internal Medicine and Pharmacology, University of Virginia School of Medicine, 22908, Charlottesville, Virginia, USA
    223 schema:name Department of Internal Medicine and Pharmacology, University of Virginia School of Medicine, 22908, Charlottesville, Virginia, USA
    224 rdf:type schema:Organization
    225 grid-institutes:grid.34477.33 schema:alternateName Department of Biochemistry, University of Washington, 98195, Seattle, Washington, USA
    226 schema:name Department of Biochemistry, University of Washington, 98195, Seattle, Washington, USA
    227 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...